Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation

View through CrossRef
Background: PCSK6 cleaves and activates growth factors involved in cell differentiation and Pcsk6-/- mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia. We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels. We therefore hypothesize that the processes of angiogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and that PCSK6 plays a role in these processes. Methods: Association between SNPs near the PCSK6 gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium. Associations of angiogenic factors with PCSK6 (transcriptomic and proteomic) and patient symptomatology were explored in a biobank of plaque endarterectomies (BiKE). Morpholino technology was used for Pcsk6 knockdown in zebrafish, coupled with vascular phenotype studies. Pcsk6-/- mice were used to study the expression of vasculogenesis related genes and vascular morphology at baseline (12 weeks). Results: Rs7178801 and rs11639051 in the PCSK6 gene were found to relate to plasma PDGFB and VEGFD levels. TGFB2, VEGFA, VEGFC, PDGFA and PLAUR associated with patients symptomatology in BiKE and correlated with PCSK6 levels. Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels along with cerebral and myocardial haemorrhage hemorrhage. Expression of angiogenic factors; Vegfa, Vegfb, Angpt1 and Tgfb2 were altered in the heart, liver and adipose tissue in Pcsk6-/- mice. Vessel density, length and branch numbers were reduced in the Pcsk6 -/- compared to the controls in the superficial but more significantly in the deep peripheral vessels. The smooth muscle cell coverage of the retinal vasculature was also reduced in the Pcsk6 -/- mice vs controls and Pdgfa was significantly downregulated compared to controls in mouse retinas. Conclusions: PCSK6 associates with levels of angiogenic factors on the genetic, transcriptomic and proteomic level. Lack of Pcsk6 in mice and zebrafish led to vascular patterning defects. Further planned studies will examine PCSK6 in pathological neovascularization.
Title: Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation
Description:
Background: PCSK6 cleaves and activates growth factors involved in cell differentiation and Pcsk6-/- mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia.
We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels.
We therefore hypothesize that the processes of angiogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and that PCSK6 plays a role in these processes.
Methods: Association between SNPs near the PCSK6 gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium.
Associations of angiogenic factors with PCSK6 (transcriptomic and proteomic) and patient symptomatology were explored in a biobank of plaque endarterectomies (BiKE).
Morpholino technology was used for Pcsk6 knockdown in zebrafish, coupled with vascular phenotype studies.
Pcsk6-/- mice were used to study the expression of vasculogenesis related genes and vascular morphology at baseline (12 weeks).
Results: Rs7178801 and rs11639051 in the PCSK6 gene were found to relate to plasma PDGFB and VEGFD levels.
TGFB2, VEGFA, VEGFC, PDGFA and PLAUR associated with patients symptomatology in BiKE and correlated with PCSK6 levels.
Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels along with cerebral and myocardial haemorrhage hemorrhage.
Expression of angiogenic factors; Vegfa, Vegfb, Angpt1 and Tgfb2 were altered in the heart, liver and adipose tissue in Pcsk6-/- mice.
Vessel density, length and branch numbers were reduced in the Pcsk6 -/- compared to the controls in the superficial but more significantly in the deep peripheral vessels.
The smooth muscle cell coverage of the retinal vasculature was also reduced in the Pcsk6 -/- mice vs controls and Pdgfa was significantly downregulated compared to controls in mouse retinas.
Conclusions: PCSK6 associates with levels of angiogenic factors on the genetic, transcriptomic and proteomic level.
Lack of Pcsk6 in mice and zebrafish led to vascular patterning defects.
Further planned studies will examine PCSK6 in pathological neovascularization.

Related Results

Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein convertase subtilisin/kexin 6 (PCSK6) is a secreted serine protease expressed in most major organs, where it cleaves a wide range of growth factors, signaling molecules,...
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
The selective pressures challenging the human population leave genetic signatures. This study was designed to detect positive and balancing selection on the proprotein convertase s...
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Background: The focus of this study was the selection of a single chain variable fragment antibody (scFv) against subtilisin BRC, a fibrinolytic enzyme using phage display, and to...
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
Proprotein convertase subtilisin/Kexin type 9 (PCSK9) is a proteolytic enzyme that indirectly regulates serum LDL cholesterol by destroying LDL receptors. In clinical studies, the ...
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech Helobdella
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech Helobdella
Abstract Intercellular communication is quintessential for multicellularity and often mediated by secreted peptide ligands. In Metazoa, proprotei...

Back to Top